LONDON, April 16, 2024 (GLOBE NEWSWIRE) — GLOBAL pet allergy treatment market expected value of From USD 2.2 billion in 2024 to USD 3.8 billion in 2031.The market is probably CAGR 8.12% During the forecast period from From 2024 to 2031.
The growing trend of pet humanization and companionship is expected to increase the demand for pet allergy treatments. As more people consider their pets to be part of the family, they will seek effective solutions to manage their pet's allergies and improve their quality of life.
A sample copy of the report is available at: https://www.fairfieldmarketresearch.com/report/pet-allergy-treatment-market/request-sample
Report scope
| Report attributes | detail | |
| base year | 2023 | |
| Forecast year | 2024 – 2031 | |
| Market size in 2024 | 2.2 billion USD | |
| Estimated market size in 2031 | USD 3.8 billion | |
| CAGR | 8.12% | |
| The driving force behind growth |
|
|
| segmentation |
|
|
| Regional coverage |
|
|
The pet allergy treatment market has been growing steadily over the years due to various factors such as increasing prevalence of pet allergies, rising pet ownership, advances in veterinary medicine, and growing awareness among pet owners about their pet's health. Masu.
There is an increasing emphasis on preventive medical care for pets, including regular health checkups, vaccinations, and allergy testing. Pet owners are becoming increasingly proactive in identifying and addressing potential health problems, including allergies, early on.
Rising awareness about pet allergies, their causes, symptoms, and treatments is expected to further propel the market growth. The pet allergy treatment market is poised to continue growing due to factors such as increasing pet ownership, technological advancements, and growing awareness of pet health.
Market players must focus on innovation, regulatory compliance, and consumer education to capitalize on the opportunities of this evolving market environment.
For more industry insights, see below. https://www.fairfieldmarketresearch.com/report/pet-allergy-treatment-market
Key research insights
- Antihistamines and corticosteroids continue to be the mainstay of symptomatic treatment for pet allergies.
- Allergen immunotherapy remains a cornerstone of the allergy treatment market.
- Europe stands out as an important market for pet allergy treatments.
- The pet allergy treatment market is dominated by North America.
Insights into segmentation analysis
Antihistamines and corticosteroids remain mainstream
- Antihistamines and corticosteroids continue to be the mainstay of symptomatic treatment for pet allergies. These drugs quickly relieve itching, sneezing, and other allergy symptoms by blocking histamine receptors or suppressing inflammation.
- The availability of new generation antihistamines with improved safety profiles and once-daily dosing schedules has increased patient adherence.
- Concerns about long-term use of corticosteroids, including the potential for systemic side effects and rebound symptoms upon discontinuation, highlight the need for alternative treatment options.
Allergen immunotherapy remains the cornerstone of pet allergy treatment
- Allergen immunotherapy, including subcutaneous and sublingual formulations, remains the cornerstone of pet allergy treatment. These products work by exposing the patient to gradually increasing doses of the allergen, desensitizing the immune system.
- Advances in formulation and delivery methods, such as fast-dissolving sublingual tablets, have increased acceptance and compliance of AIT among patients.
- The growing demand for personalized medicine is driving the development of customized allergen mixtures that increase efficacy and minimize side effects.
Key report highlights
- The number of people owning pets is increasing due to factors such as urbanization, reduced loneliness, and lifestyle changes, and the demand for pet allergy treatment is increasing.
- The prevalence of pet allergies, both in pets themselves and in humans allergic to pets, is increasing.
- Continuing research and development efforts lead to the discovery of new treatments and therapeutic approaches for pet allergies.
Insights into regional analysis
North America dominates pet allergy treatment market
- North America dominates the pet allergy treatment market due to several factors.
- Pet ownership is high in this area, with dogs and cats being the most common pets.
- This high ownership contributes to the high demand for allergy treatments.
- The region has a well-developed medical infrastructure and high awareness of pet allergies, leading to increased diagnosis and treatment.
Europe stands out as an important market for pet allergy treatments
- This region has a deep-rooted culture of keeping pets, especially dogs and cats.
- As the number of pets increases, so does the demand for allergy treatment options.
- Europe boasts an advanced healthcare system and there is widespread awareness of pet allergies among both pet owners and healthcare professionals.
Major companies introduced worldwide pet allergy treatment market
- Zoetis Animal Healthcare
- Vetoquinol SA
- Decla Pharmaceuticals PLC
- Norbrook Laboratories Limited
- Elanco Animal Health
- Billback SA
- Bayer AG
- Idex Laboratories Co., Ltd.
- Boehringer Ingelheim GmbH
- Filbo Animal Health
- Pet iQ Co., Ltd.
- Ceva Sante Animale
- Merck & Co. (USA)
- Vetiquinol SA
Global Pet Allergy Treatment Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024 to 2031 – (By Drug Class, By Indication Coverage, By Pet Coverage, By Dosage Coverage, By Distribution Channel Coverage by company, geographic coverage, and company): https://www.fairfieldmarketresearch.com/report/pet-allergy-treatment-market
About us
Fairfield Market Research is a market research provider based in the UK. Fairfield offers a wide range of services, from customized reports to consulting solutions. With a strong presence in Europe, Fairfield operates globally and helps companies navigate economic cycles with a rapid response and multifaceted approach. The company values insightful perspectives on global issues and is backed by a highly experienced team of researchers. A powerful repository of syndicated market research reports that are continuously published and updated to ensure a rapid response to ever-changing customer needs.
contact
fairfield market research
london, united kingdom
UK +44 (0)20 30025888
USA (Toll Free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
LinkedIn | Twitter
